Ebola virus and other infectious diseases
Active Awarded Last action
- Contract number
- 75N91018F00059
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $56,381,886
Award facts
- Opportunity
-
- N01CO5240180 Solicitation number
- Operations and Technical Support for the Frederick National Laboratory for Cancer Research (FLNCR), a Federally Funded Research and Development Center (FFRDC) Award Notice · Posted Apr 27, 2015
- Contract value 100% obligated
- $56,381,886.25 Current and potential, with all options
- Completion date 81% complete
- Current and potential, with all options
- Funding agency
- National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
- NAICS code
- 561210 Facilities Support Services
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21702, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$8,429,694 | |
| Terminate for Convenience | $0 | |
| Other Administrative Action | -$86,576 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $19,442,847 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $2,133,449 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $13,043,916 | |
| Original award | $30,277,944 |
Show all 21
About this award
Leidos Biomedical Research Inc., a subsidiary of Leidos Holdings Inc. and Federally Funded Research and Development Center (FFRDC) contractor, received a delivery order award valued at $56.4 million from the National Institute of Allergy and Infectious Diseases (NIAID) for support of infectious disease research, with an ultimate completion date of September 21, 2028. The contract, awarded on September 30, 2018, uses cost-plus-fixed-fee pricing with no set-aside designation and is based in Frederick, Maryland. The work encompasses research on Ebola virus disease and other emerging infectious diseases, including the assessment of immune response to Ebola virus disease as modulated by vaccines and medical countermeasures under the PALM (Partnership for Research on Ebola Virus in Liberia) program portfolio.
The prime contractor has engaged multiple subcontractors to execute the contract scope, including Mitchell Group Inc., a minority-owned, veteran-owned small business based in Washington, D.C., which has provided operational support, human resources management, logistics, clinical research site operations, and facilities infrastructure management across multiple task orders since 2019. Additional subcontractors include FHI Clinical Inc., providing clinical monitoring and research support services, and Incadence Strategic Solutions LLC, supporting biometric platform management for clinical research studies in West Africa. The contract work supports critical infectious disease research operations across international locations, including the Democratic Republic of Congo, with responsibilities spanning site preparedness, participant enrollment, laboratory services, pharmacy support, and biospecimen management to advance treatment and prevention options for emerging diseases.
Quick answers
Who was awarded contract 75N91018F00059?
75N91018F00059 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 30, 2018.
How much is contract 75N91018F00059 worth?
The government has obligated $56,381,886 on 75N91018F00059.
Which agency awarded contract 75N91018F00059?
National Cancer Institute (National Institutes of Health) awarded 75N91018F00059, with funding from National Institute of Allergy and Infectious Diseases (National Institutes of Health).
Is contract 75N91018F00059 an order under another contract?
Yes. 75N91018F00059 is a delivery order under HHSN261201500003I, an indefinite delivery contract.
Was contract 75N91018F00059 competed?
The extent of competition for 75N91018F00059 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award